Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients: second planned interim analysis of the HD18 study

Saved in:
Bibliographic Details
Other Authors: Borchmann, Peter (Other) , Meißner, Julia (Other)
Format: Article (Journal) Conference Paper
Language:English
Published: 2014
In: Blood
Year: 2014, Volume: 124, Issue: 21
ISSN:1528-0020
Subjects:
Online Access:Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497119694395
Get full text
Author Notes:Peter Borchmann, Heinz Haverkamp, Andreas Lohri, Stefanie Kreissl, Richard Greil, Jana Markova, Michaela Feuring-Buske, Julia Meissner, Ulrich Dührsen, Nicole Engel, Ulrich Keller, Georg Maschmeyer, Markus Dietlein, Carsten Kobe, Michael Fuchs, Volker Diehl, Andreas Engert
Description
Item Description:Gesehen am30.06.2015
Physical Description:Online Resource
ISSN:1528-0020